Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | HPGD | P15428 | 3/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.52 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.52 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.52 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.52 |
| ▸ | MAOA | P21397 | 1/20 | 0.52 |
| ▸ | DRD1 | P21728 | 1/20 | 0.52 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.52 |
| ▸ | HTR2B | P41595 | 1/20 | 0.52 |
| ▸ | CCR2 | P41597 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | MIF | P14174 | 5/20 | 0.46 |
| ▸ | APLNR | P35414 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29374052 | 0.87 | ALDH1A1 (0.62) | CYP3A4ALDH1A1HPGDTDP1ABCB11 | |
| SCHEMBL207554 | 0.87 | ALDH1A1 (0.62) | CYP3A4ALDH1A1HPGDTDP1ABCB11 | |
| SCHEMBL15431 | 0.87 | CYP3A4 (0.64) | CYP3A4ALDH1A1HPGDTDP1ABCB11 | |
| SCHEMBL29395383 | 0.87 | CYP3A4 (0.64) | CYP3A4ALDH1A1HPGDTDP1ABCB11 | |
| Benzene SCHEMBL28766229 | 0.85 | CYP3A4 (0.61) | CYP3A4ALDH1A1HPGDTDP1ABCB11 | |
| SCHEMBL30244709 | 0.85 | CYP3A4 (0.61) | CYP3A4ALDH1A1HPGDTDP1ABCB11 | |
| Ammonia Solution, Strong SCHEMBL28158244 | 0.85 | CYP3A4 (0.61) | CYP3A4ALDH1A1HPGDTDP1ABCB11 | |
| Fluoride SCHEMBL28813057 | 0.85 | CYP3A4 (0.61) | CYP3A4ALDH1A1HPGDTDP1ABCB11 | |
| Water SCHEMBL28526910 | 0.85 | CYP3A4 (0.61) | CYP3A4ALDH1A1HPGDTDP1ABCB11 | |
| SCHEMBL28944561 | 0.84 | CYP3A4 (0.40) | CYP3A4ALDH1A1HPGDTDP1ABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2411433-A1 | POLYURETHANES, ARTICLES AND COATINGS PREPARED THEREFROM AND METHODS OF MAKING THE SAME | PPG Industries Ohio, Inc. (US) | 2012-02-01 | — | — | EP | disclosed |
| WO-2010110784-A1 | POLYURETHANES, ARTICLES AND COATINGS PREPARED THEREFROM AND METHODS OF MAKING THE SAME | PPG INDUSTRIES OHIO, INC. (US) | 2010-09-30 | — | — | WO | disclosed |
| US-7144989-B2 | Pegylated non-hypertensive hemoglobins, methods of preparing same, and uses thereof | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) | 2006-12-05 | — | — | US | disclosed |
| US-7084112-B2 | Activated polyethylene glycol compounds | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) | 2006-08-01 | — | — | US | disclosed |
| US-6962954-B2 | Activated polyethylene glycol compounds | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) | 2005-11-08 | — | — | US | disclosed |
| US-20050159339-A1 | Pegylated non-hypertensive hemoglobins, methods of preparing same, and uses thereof | ALBERT EINSTEIN COLLEGE OF MEDICINE, INC. | 2005-07-21 | — | — | US | disclosed |
| US-20040147736-A1 | Activated polyethylene glycol compounds | ALBERT EINSTEIN COLLEGE OF MEDICINE, INC. | 2004-07-29 | — | — | US | disclosed |
| US-20040127697-A1 | Activated polyethylene glycol compounds | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY | 2004-07-01 | — | — | US | disclosed |
| US-6737524-B2 | ARYL ISOTHIOCYANATE DERIVATIVES; ATTACHING TO BIOMOLECULES SUCH AS PROTEINS OR PEPTIDES; ENHANCING IN VIVO CIRCULATION HALFLIFE | Smith, Paul K. | 2004-05-18 | — | — | US | disclosed |
| US-20030187248-A1 | Activated polyethylene glycol compounds | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY | 2003-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030187248-A1 | Activated polyethylene glycol compounds | ADH1C, PIGO, AADAC | CYP3A4 1790/4885ALDH1A1 547/4885HPGD 2705/4885 |
| US-20040127697-A1 | Activated polyethylene glycol compounds | ADH1C, PIGO, AADAC | CYP3A4 1790/4885ALDH1A1 547/4885HPGD 2705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.